Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05524662 · ClinicalTrials.gov registry record · NA

Clinical and Histological Evaluation of BTL-785F Device for Non-invasive Treatment of Face

A NA study, sponsored by BTL Industries.

Completed
Registry status
NA
Development phase
7
Enrollment target

NCT05524662 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 7 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05524662, a NA study, has completed, sponsored by BTL Industries.

COMPLETED
Registry status
NA
Development phase
7 participants
Enrollment target

Study Summary

This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-7 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and overall improvement of facial appearance.

Interventions

  • DEVICE BTL-785-7

Trial Details

FieldValue
Enrollment Target 7 participants
Start Date 2022-06-15
Est. Completion 2023-03-31
Phase NA

Sponsor

BTL Industries

40 total trials

What the Registry Record Tells You About NCT05524662

The ClinicalTrials.gov registry entry for NCT05524662 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which BTL-785-7 is the first listed.

NCT05524662 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05524662 about?

NCT05524662 is a clinical study titled "Clinical and Histological Evaluation of BTL-785F Device for Non-invasive Treatment of Face". This study will evaluate the clinical efficacy, safety and the performance of the BTL-785-7 applicator of the BTL-785F system for non-invasive treatment of facial wrinkles and overall improvement of facial appearance.

What is the current status of trial NCT05524662?

This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2022-06-15. Estimated completion is 2023-03-31.

What interventions are being tested in trial NCT05524662?

The interventions under investigation include: BTL-785-7 (DEVICE).

Who is sponsoring clinical trial NCT05524662?

This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.